Bleomycin A5 Hydrochloride for Injection Application Scope

Bleomycin A5 Hydrochloride for Injection is mainly used for the treatment of squamous carcinoma of the neck, such as lip, tongue, gums and nasopharynx.

bleomycin A5 hydrochloride for injection

Bleomycin A5 Hydrochloride For Injection Characteristics

Ingredient: Salcatonin hydrochloride

Characteristics: lip cancer, tongue cancer

Specification: 8mg

Storage: Sealed and kept in a cool and dry place.

Effective period: 30 months

Approval number: National Pharmacopoeia H12020933

Execution Standard: <<Chinese Pharmacopoeia>> 2005 Edition, Second Part

Revision date: According to the latest drug instructions.

Manufacturer: Tianjin Taihe Pharmaceutical Co.

Guidelines For The Use Of Bleomycin A5 Hydrochloride For Injection

Dosage and Administration:Osteoporosis:20ug daily or 40ug every other day, once or in divided doses; depending on the condition and patient response.
Adverse Reactions:Nausea, vomiting, dizziness, mild facial flushing with a sensation of warmth. These side effects are dose dependent and are more common with intravenous than intramuscular or subcutaneous injections, which are more common than nasal spray administration.

Medication Limitations

Contraindications: Patients with a history of hypersensitivity to bleomycin antibiotics are contraindicated. Use with caution in patients with pulmonary, hepatic or renal dysfunction.
Precautions: Fever, after the administration of the drug if the patient appears feverish phenomenon, can be given antipyretic drugs. For patients who develop high fever, the dose should be reduced in subsequent treatment, the duration of administration should be shortened, and antipyretic or antiallergic agents should be given before and after administration. Patients with allergic symptoms such as skin rash should stop the administration of the drug, the symptoms may disappear naturally after stopping the drug.

Bleomycin A5 Hydrochloride for Injection Interactions

None. Inform your doctor of all medications you are using before starting treatment.

Note:

If there is a new packaging for the drug, the new packaging shall prevail. The above information is sourced from HongKong DengYue Medicine. It is only for internal discussion among medical staff and does not serve as a basis for medication. For specific medication guidelines, please consult the attending physician.